Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments

被引:1313
作者
Hernando, MD [1 ]
Mezcua, M
Fernández-Alba, AR
Barceló, D
机构
[1] Univ almeria, Dept Analyt Chem, Almeria 04120, Spain
[2] IIQAB, Dept Environm Chem, Barcelona 08034, Spain
关键词
environmental risk assessment; pharmaceuticals; residues; wastewaters; surface waters; sediments;
D O I
10.1016/j.talanta.2005.09.037
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Pharmaceutical residues in the environment, and their potential toxic effects, have been recognized as one of the emerging research area in the environmental chemistry. The increasing attention, on pharmaceutical residues as potential pollutants, is due that they often have similar physico-chemical behaviour than other harmful xenobiotics which are persistent or produce adverse effects. In addition, by contrast with regulated pollutants, which often have longer environmental half-lives, its continuous introduction in the environment may make them "pseudopersistents". Pharmaceutical residues and/or their metabolites are usually detected in the environment at trace levels, but, even that, low concentration levels (ng/L or mu g/L) can induce to toxic effects. In particular, this is the case of antibiotics and steroids that cause resistance in natural bacterial populations or endocrine disruption effects. In this study, an overview of the environmental occurrence and ecological risk assessment of pharmaceutical residues is presented from literature data. Risk Quotient method (RQ) was applied as a novel approach to estimate the environmental risk of pharmaceuticals that are most frequently detected in wastewater effluents, surface waters and sediments. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:334 / 342
页数:9
相关论文
共 60 条
[1]   Natural and synthetic organic compounds in the environment - a symposium report [J].
Ariese, F ;
Ernst, WHO ;
Sijm, DTHM .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2001, 10 (03) :65-80
[2]   Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom [J].
Ashton, D ;
Hilton, M ;
Thomas, KV .
SCIENCE OF THE TOTAL ENVIRONMENT, 2004, 333 (1-3) :167-184
[3]  
BEAUSSE J, 2004, TRENDS ANAL CHEM, V23, P10
[4]   On-line membrane preconcentration for continuous monitoring of trace pharmaceuticals [J].
Bishop, EJ ;
Mitra, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (01) :81-86
[5]   Pharmaceuticals in the aquatic environment - a comparison of risk assessment strategies [J].
Bound, JP ;
Voulvoulis, N .
CHEMOSPHERE, 2004, 56 (11) :1143-1155
[6]   Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada [J].
Boyd, GR ;
Reemtsma, H ;
Grimm, DA ;
Mitra, S .
SCIENCE OF THE TOTAL ENVIRONMENT, 2003, 311 (1-3) :135-149
[7]   Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration [J].
Clara, M ;
Strenn, B ;
Kreuzinger, N .
WATER RESEARCH, 2004, 38 (04) :947-954
[8]   Initial risk assessment for three β-blockers found in the aquatic environment [J].
Cleuvers, M .
CHEMOSPHERE, 2005, 59 (02) :199-205
[9]   Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects [J].
Cleuvers, M .
TOXICOLOGY LETTERS, 2003, 142 (03) :185-194
[10]   Pharmaceuticals and personal care products in the environment: Agents of subtle change? [J].
Daughton, CG ;
Ternes, TA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 :907-938